Irvine Clinical Research
Ralph Lee is the CEO of Irvine Clinical Research and Healthy Brain Clinic, with extensive experience in clinical trial management and neurodegenerative disease research. Since 2005, Ralph has overseen operations for over 300 FDA Phase I-IV clinical trials at Irvine Clinical Research, managing site network leadership, business development, participant recruitment, and corporate development among other responsibilities. Previous roles include serving as a Neurodegenerative Disease Research Advisor at Eli Lilly, where Ralph provided strategic guidance on clinical research related to Alzheimer's Disease. Additionally, Ralph has consulted for various companies, contributing expertise in clinical trial execution and technology solutions to enhance the research process. Ralph holds a B.A. in Operations Research and Management Science from the University of California, Berkeley.
This person is not in any teams
Irvine Clinical Research
Irvine Clinical Research is an independent, physician investigator-owned clinic specializing in Phase 2-3 sponsored clinical trials in neurology and psychiatry. We have a demonstrated history of enrolling subjects quickly, producing quality data to Sponsors, and ensuring the highest standard of patient care. Our largest areas of study are in Mild Cognitive Impairment/Early Alzheimer's Disease and Depression therapeutic trials. According to publicly available CMS data, Irvine Clinical Research is the top independent site in Alzheimer’s Disease clinical trials in the state of California, as measured by industry research grants.